ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Total Debt History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | ₹1,624 Cr | ₹1,063 Cr | ₹1,214 Cr | ₹1,307 Cr | ₹2,580 Cr |
What is the latest Total Debt ratio of ALKEM LABORATORIES ?
| Year | Total Debt |
|---|---|
| Mar2026 | ₹1,624 Cr |
| Mar2025 | ₹1,063 Cr |
| Mar2024 | ₹1,214 Cr |
| Mar2023 | ₹1,307 Cr |
| Mar2022 | ₹2,580 Cr |
How is Total Debt of ALKEM LABORATORIES Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,624 Cr | 52.76 | |
| Mar2025 | ₹1,063 Cr | -12.45 | |
| Mar2024 | ₹1,214 Cr | -7.13 | |
| Mar2023 | ₹1,307 Cr | -49.34 | |
| Mar2022 | ₹2,580 Cr | - | |
Compare Total Debt of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹62,971.8 Cr | 2.2% | -1.8% | -5.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | 5.2% | 4.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹273,565.0 Cr | 3.6% | 7.6% | 50.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,332.0 Cr | 3.4% | 0.7% | 32.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,532.0 Cr | 2.3% | 14% | 13.6% | Stock Analytics | |
| CIPLA | ₹113,831.0 Cr | 2% | 6% | -6.7% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | 2.2% |
-1.8% |
-5.9% |
| SENSEX | 8.8% |
10.9% |
-4% |
You may also like the below Video Courses